Nantheia A1002N5S

Nantheia A1002N5S is an investigational oral cannabidiol (CBD) formulation developed by Ananda Scientific that leverages the company’s patented Liquid Structure delivery technology to enhance CBD’s bioavailability, water solubility, stability, and gastrointestinal absorption.[5][6][12] Each softgel capsule contains 50 mg of pharmaceutical-grade CBD isolate formulated in a liquid-structure lipid system designed to enable rapid and efficient intestinal uptake.[2][5][7][12] The product is being evaluated in multiple FDA‑approved clinical trials as a potential treatment for post-traumatic stress disorder (including PTSD with comorbid mild traumatic brain injury), social anxiety disorder, and radiculopathic pain, where CBD’s proposed mechanisms include modulation of endocannabinoid signaling and broader neuromodulatory and anxiolytic effects.[1][5][7][12][13][15]

Brand names

Nantheia A1002N5S

Other names

Nantheia A1002N5SNantheia A1002A1002N5SA-1002N5SA 1002N5S